Boryung Corporation Logo

Boryung Corporation

A healthcare company developing pharmaceuticals and investing in health sector innovation.

003850 | KO

Overview

Corporate Details

ISIN(s):
KR7003850005
LEI:
Country:
South Korea
Address:
서울 종로구 원남동 보령빌딩 66-21, 종로구

Description

Boryung Corporation is a fully integrated healthcare company founded in 1957. Its core business encompasses the research, development, manufacturing, and global commercialization of pharmaceutical products, with a significant presence in the cardiovascular therapeutic area. The company is distinguished by its pioneering 'Care in Space' (CIS) initiative, which focuses on developing healthcare solutions for humans in extreme environments and leveraging space for new research opportunities. In addition to its pharmaceutical operations, Boryung functions as a healthcare investment company, fostering innovation across the health sector. The company's diverse portfolio includes prescription drugs, over-the-counter products, and a pipeline aimed at addressing future medical needs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-12-16 00:00
주주명부폐쇄기간또는기준일설정
Korean HTML 4.1 KB
2025-08-14 00:00
반기보고서 (2025.06)
Korean HTML 3.8 MB
2025-08-08 00:00
공정거래자율준수프로그램운영현황(안내공시)
Korean HTML 17.3 KB
2025-07-31 00:00
연결재무제표기준영업(잠정)실적(공정공시)
Korean HTML 15.1 KB
2025-06-12 00:00
주식등의대량보유상황보고서(일반)
Korean HTML 138.9 KB
2025-06-12 00:00
자기주식처분결과보고서
Korean HTML 16.6 KB
2025-06-12 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 24.2 KB
2025-06-12 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 24.2 KB
2025-06-05 00:00
주요사항보고서(자기주식처분결정)
Korean HTML 29.0 KB
2025-06-02 00:00
지속가능경영보고서등관련사항(자율공시)
Korean HTML 10.2 KB
2025-06-02 00:00
기업지배구조보고서공시
Korean HTML 770.4 KB
2025-05-23 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 27.4 KB
2025-05-15 00:00
분기보고서 (2025.03)
Korean HTML 2.2 MB
2025-04-29 00:00
연결재무제표기준영업(잠정)실적(공정공시)
Korean HTML 15.0 KB
2025-04-25 00:00
투자판단관련주요경영사항
Korean HTML 16.8 KB

Automate Your Workflow. Get a real-time feed of all Boryung Corporation filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Boryung Corporation

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Boryung Corporation via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.